QA: BIOXYTRAN INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2023_BIOXYTRAN_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, BIOXYTRAN INC

  xvar xval
0 AssetsCurrent 295,401
1 IntangibleAssetsNetIncludingGoodwill 75,535
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 3,663,482
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 933,742
9 ResearchAndDevelopmentExpense 977,768
10 remainder_Expenses 222,602
11 remainder_Revenues 0
12 remainder_NetIncome -523,192
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 370,936
1 Liabilities 3,663,482
2 Expenses 2,134,112
3 Revenues 0
4 StockholdersEquity -3,292,546
5 NetIncome -2,657,304
6 ComprehensiveNetIncome -2,657,304
7 BaseVar 3,345,861
8 EconomicCapitalRatio -4.12

Edgar->Model Mapping

Feature Distribution

Change over Time